Cargando…
Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination
Despite the approval of vaccines, monoclonal antibodies and restrictions during the pandemic, the demand for new efficacious and safe antivirals is compelling to boost the therapeutic arsenal against the COVID-19. The viral 3-chymotrypsin-like protease (3CL(pro)) is an essential enzyme for replicati...
Autores principales: | Stefanelli, Irina, Corona, Angela, Cerchia, Carmen, Cassese, Emilia, Improta, Salvatore, Costanzi, Elisa, Pelliccia, Sveva, Morasso, Stefano, Esposito, Francesca, Paulis, Annalaura, Scognamiglio, Sante, Di Leva, Francesco Saverio, Storici, Paola, Brindisi, Margherita, Tramontano, Enzo, Cannalire, Rolando, Summa, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068823/ https://www.ncbi.nlm.nih.gov/pubmed/37043904 http://dx.doi.org/10.1016/j.ejmech.2023.115311 |
Ejemplares similares
-
Easy access to α-ketoamides as SARS-CoV-2 and MERS M(pro) inhibitors via the PADAM oxidation route
por: Pelliccia, Sveva, et al.
Publicado: (2022) -
SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells
por: Cannalire, Rolando, et al.
Publicado: (2020) -
Targeting SARS-CoV-2
Proteases and Polymerase
for COVID-19 Treatment: State of the Art and Future Opportunities
por: Cannalire, Rolando, et al.
Publicado: (2020) -
Unlocking STING as a Therapeutic Antiviral Strategy
por: Paulis, Annalaura, et al.
Publicado: (2023) -
Continuous-Flow Technology for Chemical Rearrangements:
A Powerful Tool to Generate Pharmaceutically Relevant Compounds
por: Alfano, Antonella Ilenia, et al.
Publicado: (2023)